Androgen deprivation therapy through bilateral orchiectomy: increased metabolic risks.
about
Clinical significance of androgen secretion disorders in men with a malignancy.Quantifying the evidence for the risk of metabolic syndrome and its components following androgen deprivation therapy for prostate cancer: a meta-analysis.Androgen deprivation therapy is associated with diabetes: Evidence from meta-analysisNeuronal androgen receptor regulates insulin sensitivity via suppression of hypothalamic NF-κB-mediated PTP1B expression.Metabolic syndrome in patients with prostate cancer undergoing intermittent androgen-deprivation therapy
P2860
Androgen deprivation therapy through bilateral orchiectomy: increased metabolic risks.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Androgen deprivation therapy through bilateral orchiectomy: increased metabolic risks.
@en
Androgen deprivation therapy through bilateral orchiectomy: increased metabolic risks.
@nl
type
label
Androgen deprivation therapy through bilateral orchiectomy: increased metabolic risks.
@en
Androgen deprivation therapy through bilateral orchiectomy: increased metabolic risks.
@nl
prefLabel
Androgen deprivation therapy through bilateral orchiectomy: increased metabolic risks.
@en
Androgen deprivation therapy through bilateral orchiectomy: increased metabolic risks.
@nl
P2093
P2860
P356
P1476
Androgen deprivation therapy through bilateral orchiectomy: increased metabolic risks.
@en
P2093
Chao Zhang
Dong-Ming Liu
Jian-Jun Sha
Jian-Wei Lv
Juan-Jie Bo
Lian-Hua Zhang
Yi-Ran Huang
P2860
P304
P356
10.1038/AJA.2011.83
P577
2011-07-25T00:00:00Z